Effect of a new functional CYP3A4 polymorphism on tacrolimus dose requirement and trough blood levels in stable renal transplant patients

被引：0
|
作者：
Elens, L. [1 ]
van Schaik, R. [1 ]
Panin, N. [2 ]
De Meyer, M. [3 ]
Wallemacq, P. [2 ]
Lison, D. [2 ]
Mourad, M. [3 ]
Haufroid, V [2 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
[3] Clin Univ St Luc, Kidney & Pancreas Transplantat Unit, B-1200 Brussels, Belgium
来源：
THERAPEUTIC DRUG MONITORING | 2011年 / 33卷 / 04期
关键词：
CYP3A4; CYP3A5; tacrolimus; kidney transplantation; pharmacogenetics; pharmacokinetics; single nucleotide polymorphism;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：507 / 507
页数：1
相关论文
共 50 条
  • [41] A comparison of the effects of CYP3A5 polymorphism on tacrolimus blood concentrations measured by 4 immunoassay methods in renal transplant patients
    Akamine, Y.
    Kagaya, H.
    Ohkubo, T.
    Satoh, S.
    Miura, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 181 - 188
  • [42] The Genetic Polymorphism of CYP3A4 rs2242480 is Associated with Sirolimus Trough Concentrations among Adult Renal Transplant Recipients
    Lolita, Lolita
    Zheng, Ming
    Zhang, Xiang
    Han, Zhijian
    Tao, Jun
    Fei, Shuang
    Wang, Zijie
    Guo, Miao
    Yang, Haiwei
    Ju, Xiaobing
    Tan, Ruoyun
    Wei, Ji-Fu
    Gu, Min
    CURRENT DRUG METABOLISM, 2020, 21 (13) : 1052 - 1059
  • [43] Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
    Ranjana Singh
    Aneesh Srivastava
    Rakesh Kapoor
    Raj K. Sharma
    Rama D. Mittal
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 380 : 169 - 177
  • [44] Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
    Singh, Ranjana
    Srivastava, Aneesh
    Kapoor, Rakesh
    Sharma, Raj K.
    Mittal, Rama D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (02) : 169 - 177
  • [45] Receptor-donor CYP3A5 and CYP3A4 genotype testing in liver transplant patients and its influence in tacrolimus blood levels: a retrospective study
    Prieto, J. L. Rubio
    Macher, H.
    Bravo, M. A. Gomez
    Silva, J. L. Garcia de Veas
    Artacho, G. Suarez
    Rodriguez, A. Rodriguez
    Pozo, C. Sanchez
    Guerrero, J.
    Rubio, A.
    CLINICAL CHEMISTRY, 2024, 70 : I222 - I222
  • [46] EFFECT OF CYP3A5 GENE POLYMORPHISMS ON THE LEVELS OF TACROLIMUS IN TURKISH RENAL TRANSPLANT PATIENTS
    Ciftci, Hayriye Senturk
    Caliskan, Yasar Kerem
    Guney, Ilter
    Ayna, Tulay Kilicaslan
    Bakkaloglu, Huseyin
    Nane, Ismet
    Aydin, Ali Emin
    Turkmen, Aydin
    Gurtekin, Mehmet
    TISSUE ANTIGENS, 2012, 79 (06): : 495 - 495
  • [47] Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, Homan J. J.
    Bemelman, F.
    de Fijter, J. W.
    Guchelaar, H. J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 672 - 672
  • [48] Impact of the CYP3A4*1G Polymorphism and Its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Japanese Renal Transplant Recipients
    Satoh, S.
    Miura, M.
    Kagaya, H.
    Saito, M.
    Numakura, K.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 83 - 83
  • [49] A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.
    Elens, L.
    Bouarmar, R.
    Hesselink, D. A.
    Haufroid, V.
    van Gelder, T.
    van Schaik, R. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S107 - S107
  • [50] Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients
    Ajmi, M.
    Sahtout, W.
    Omezzine, A.
    Amor, D.
    Abderahmene, A.
    Azzabi, A.
    Ben-Rejeb, N.
    Achour, A.
    Bouslama, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
12345